443 related articles for article (PubMed ID: 18705685)
21. An outbreak of hepatitis A virus infection with a high case-fatality rate among injecting drug users.
Spada E; Genovese D; Tosti ME; Mariano A; Cuccuini M; Proietti L; Giuli CD; Lavagna A; Crapa GE; Morace G; Taffon S; Mele A; Rezza G; Rapicetta M
J Hepatol; 2005 Dec; 43(6):958-64. PubMed ID: 16143420
[TBL] [Abstract][Full Text] [Related]
22. A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.
Removille N; Origer A; Couffignal S; Vaillant M; Schmit JC; Lair ML
BMC Public Health; 2011 May; 11():351. PubMed ID: 21595969
[TBL] [Abstract][Full Text] [Related]
23. Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection.
Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Barrio E
Am J Gastroenterol; 2000 May; 95(5):1316-22. PubMed ID: 10811346
[TBL] [Abstract][Full Text] [Related]
24. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
de la Hoz F; Perez L; de Neira M; Hall AJ
Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
[TBL] [Abstract][Full Text] [Related]
25. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.
Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414
[TBL] [Abstract][Full Text] [Related]
26. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
Imani R; Karimi A; Rouzbahani R; Rouzbahani A
East Mediterr Health J; 2008; 14(5):1136-41. PubMed ID: 19161086
[TBL] [Abstract][Full Text] [Related]
27. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003.
Suntharasamai P; Martin M; Vanichseni S; van Griensven F; Mock PA; Pitisuttithum P; Tappero JW; Sangkum U; Kitayaporn D; Gurwith M; Choopanya K;
Addiction; 2009 Feb; 104(2):235-42. PubMed ID: 19149819
[TBL] [Abstract][Full Text] [Related]
29. High seroprevalence of bloodborne viruses among street-recruited injection drug users from Buenos Aires, Argentina.
Weissenbacher M; Rossi D; Radulich G; Sosa-Estáni S; Vila M; Vivas E; Avila MM; Cuchi P; Rey J; Peralta LM
Clin Infect Dis; 2003 Dec; 37 Suppl 5():S348-52. PubMed ID: 14648445
[TBL] [Abstract][Full Text] [Related]
30. Changing serological status and low vaccination-induced protection rates against hepatitis B characterize chronic hepatitis C virus-infected injecting drug users in Greece: need for immunization policy.
Elefsiniotis IS; Pantazis KD; Ketikoglou ID; Koutsounas SI; Tsianos EV
Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1227-31. PubMed ID: 17033445
[TBL] [Abstract][Full Text] [Related]
31. Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons.
Hutchinson SJ; Wadd S; Taylor A; Bird SM; Mitchell A; Morrison DS; Ahmed S; Goldberg DJ
Vaccine; 2004 Nov; 23(2):210-4. PubMed ID: 15531039
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus.
Laurence JC
Am J Med; 2005 Oct; 118 Suppl 10A():75S-83S. PubMed ID: 16271546
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis C infection among drug users in northern Thailand.
Jittiwutikarn J; Thongsawat S; Suriyanon V; Maneekarn N; Celentano D; Razak MH; Srirak N; Vongchak T; Kawichai S; Thomas D; Sripaipan T; Netski D; Ananthakrishnan A; Nelson KE
Am J Trop Med Hyg; 2006 Jun; 74(6):1111-6. PubMed ID: 16760529
[TBL] [Abstract][Full Text] [Related]
34. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users.
Vassilev ZP; Hagan H; Lyubenova A; Tomov N; Vasilev G; Krasteva D; Des Jarlais DC
Int J STD AIDS; 2006 Sep; 17(9):621-6. PubMed ID: 16942654
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
Bailey CL; Smith V; Sands M
Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan.
Chu FY; Chiang SC; Su FH; Chang YY; Cheng SH
J Med Virol; 2009 Jun; 81(6):973-8. PubMed ID: 19382252
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor.
Baklan Z; Gorisek JR; Poljak M; Pisec A
Wien Klin Wochenschr; 2004; 116 Suppl 2():5-7. PubMed ID: 15506302
[TBL] [Abstract][Full Text] [Related]
38. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.
Tun W; Vu L; Adebajo SB; Abiodun L; Sheehy M; Karlyn A; Njab J; Ahonsi B; Issa BK; Idogho O
Int J STD AIDS; 2013 Aug; 24(8):619-25. PubMed ID: 23970571
[TBL] [Abstract][Full Text] [Related]
39. Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ
Vaccine; 2006 Mar; 24(13):2377-86. PubMed ID: 16384627
[TBL] [Abstract][Full Text] [Related]
40. Two simultaneous hepatitis B virus epidemics among injecting drug users and men who have sex with men in Buenos Aires, Argentina: characterization of the first D/A recombinant from the American continent.
Trinks J; Cuestas ML; Tanaka Y; Mathet VL; Minassian ML; Rivero CW; Benetucci JA; Gímenez ED; Segura M; Bobillo MC; Corach D; Ghiringhelli PD; Sánchez DO; Avila MM; Peralta LA; Kurbanov F; Weissenbacher MC; Simmonds P; Mizokami M; Oubiña JR
J Viral Hepat; 2008 Nov; 15(11):827-38. PubMed ID: 18507755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]